CEOs of Biopharmaceutical Companies CTLT, GSK, INCY, MRK, MRNA, PFE, SNY, TAK, UCB Share Long-Term Business Plans with Investors

Press Release

NEW YORK, June 7, 2021 /3BL Media/ —Representing $800 billion in market capitalization, nine CEOs from the biopharma sector will speak virtually about their company’s long-term approach to sustainable business, June 7-8, 2021.

Biopharma Leaders and Institutional Investors Seeking Effective, Efficient, and Decision-Useful Communications about Long-Term Business Strategy, According to New Report From CECP's CEO Investor Forum and the Biopharma Sustainability Roundtable

Research shows ESG performance is strongly predictive of long-term value creation and financial performance, when a sector-specific approach is maintained
Press Release

NEW YORK, March 22, 2021 /3BL Media/- As the world begins to emerge from under the weight of multiple crises, investors are seeking more effective and efficient ESG (environment, social, governance) communications directly from companies, which include a longer-term strategy and vision.

Join CRB for a Biomanufacturing Manufacturing Solutions Webinar

Multimedia with summary

Don't miss a discussion with our top advanced therapy medicinal product subject matter experts on how to assess expansion of production capabilities.

The webinar will take place on Tuesday, Dember 15, 2020 at 11:00 AM EST

Register for free here

Facing Pandemics and Emerging Threats, ATMP Industry Arrives at Intersection of Obstacle and Opportunity

CRB report explores challenges and solutions as cell and gene therapy organizations confront new urgency for patient therapies
Press Release

KANSAS CITY, Mo., Oct. 28, 2020 /3BL Media/ – From the global COVID-19 pandemic to rare and challenging health threats, our world seems forever on the defense against disease and in need of a nimble and efficient vaccine and therapy supply chain. But a new report from CRB, a leading global provider of biopharma manufacturing solutions, spotlights the critical conflicts threatening the speedy delivery of patient therapies.

The CEO Investor Forum Launches Partnership with the Biopharma Sustainability Roundtable to Address the Need for Stronger Industry-wide Sustainability Efforts in Biotech and Pharmaceuticals Sector

Press Release

NEW YORK, July 9,2020 /3BL Media/ — Pharmaceutical and biotech companies are actively working to enhance their sustainability efforts to increase the emphasis on long-term value creation, stakeholder engagement, and forward-looking disclosures. To support these efforts, the Biopharma Sustainability Roundtable (BSRT) has formed a partnership with CECP’s CEO Investor Forum. Together, the two groups will co-host the first sector-specific CEO-Investor Forum in June 2021.

A Unique Recycling Solution to Biopharma Single-Use Plastic Waste


Single-use plastic is a topic that receives a lot of attention in the press and has catalyzed efforts to reduce the amount that is found in the ocean. Although the bulk of this pollution comes from consumer waste, the growing use of plastic in laboratories and biopharma manufacturing has not gone unnoticed. It has been estimated that 5.5 million tons of plastic waste is being generated globally for scientific research. In biopharma manufacturing, the utilization of single-use technologies (SUT) is said to be increasing by 20-24% each year.

Jeannette Company Becomes Leader in Recycling Biopharmaceutical Waste


Triumvirate Environmental has a new way to help the pharmaceutical industry recycle plastic waste.

The Jeannette waste-management company serves clients in the life sciences, health care, education and industrial markets.

Continue Reading on

New Avenues in Biomedical Waste Management Developed

by Maura Keller
Multimedia with summary

This year is the 30th anniversary of the Medical Waste Tracking Act of 1988.


Subscribe to biopharma